Hartwig Medical Foundation

To make the right treatment decision, cancer specialists need to collect all the available diagnostic information from the patient and their tumor.

We are contributing to this work by:

Developing

innovative molecular tests, for identifying the characteristics of the tumor.

Collecting and storing

knowledge of and information about the patient and their tumor.

Integrating

the information and knowledge with treatment outcome to accelerate scientific research. This enables us to learn from the data of today’s patients and provide better treatment for the patients of tomorrow.

Vrouw en man spreken in behandelkamer met vrouwelijke arts, zittend aan een overlegtafel

Share your data

Your contribution to improving the treatment of tomorrow’s patients is important. Share your data, too!

Read more

Share your data and share our vision for the future of cancer diagnosis

Read the latest news

Towards a learning healthcare system by broad collaboration

Towards a learning healthcare system by broad collaboration

15-09-2022

Developing a new drug is expensive and takes a long time. In addition, there is only a slim chance that …

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

11-08-2022

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

10-08-2022

Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …

Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board

Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board

20-07-2022

On July 14, Prince Constantijn of the Netherlands succeeded Robbert Dijkgraaf as chairman of the Supervisory Board of Hartwig Medical …

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

14-04-2022

The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Read all our news

Read the latest blogs

The big advantage of having Hartwig Medical Foundation data available in the cloud

The big advantage of having Hartwig Medical Foundation data available in the cloud

10-03-2022

I don’t remember exactly when I first heard about Hartwig Medical Foundation and the whole genome sequencing data it has …

Read more
Read all our blogs

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl